Silco Pharmaceuticals Limited (DSE: SILCOPHL)

Silco Pharmaceuticals Revenue

Silco Pharmaceuticals had revenue of 114.69M BDT in the quarter ending September 30, 2024, with 12.27% growth. This brings the company's revenue in the last twelve months to 422.64M, down -3.30% year-over-year. In the fiscal year ending June 30, 2024, Silco Pharmaceuticals had annual revenue of 410.10M, down -11.75%.

• Revenue (ttm): 422.64M
• Revenue Growth: -3.30%
• P/S Ratio: 3.92
• Revenue / Employee: 1.35M
• Employees: 313
• Market Cap: 1.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	410.10M	-54.59M	-11.75%
Jun 30, 2023	464.70M	-94.77M	-16.94%
Jun 30, 2022	559.47M	-41.59M	-6.92%
Jun 30, 2021	601.06M	-132.59M	-18.07%
Jun 30, 2020	733.65M	-185.39M	-20.17%